Atossa Genetics Stock Fundamentals
| ATOS Stock | USD 0.72 0.03 4.35% |
Atossa Genetics fundamentals help investors to digest information that contributes to Atossa Genetics' financial success or failures. It also enables traders to predict the movement of Atossa Stock. The fundamental analysis module provides a way to measure Atossa Genetics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Atossa Genetics stock.
Atossa |
Atossa Genetics Company Shares Owned By Insiders Analysis
Atossa Genetics' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Atossa Genetics Shares Owned By Insiders | 0.05 % |
Most of Atossa Genetics' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Atossa Genetics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 0.05% of Atossa Genetics are shares owned by insiders. This is 99.67% lower than that of the Health Care Equipment & Supplies sector and 99.65% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 99.5% higher than that of the company.
Atossa Genetics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Atossa Genetics's current stock value. Our valuation model uses many indicators to compare Atossa Genetics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Atossa Genetics competition to find correlations between indicators driving Atossa Genetics's intrinsic value. More Info.Atossa Genetics is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Atossa Genetics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Atossa Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Atossa Genetics' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Atossa Genetics could also be used in its relative valuation, which is a method of valuing Atossa Genetics by comparing valuation metrics of similar companies.Atossa Genetics is currently under evaluation in shares owned by insiders category among its peers.
Atossa Fundamentals
| Return On Equity | -0.31 | ||||
| Return On Asset | -0.2 | ||||
| Current Valuation | 15.4 M | ||||
| Shares Outstanding | 125.8 M | ||||
| Shares Owned By Insiders | 0.05 % | ||||
| Shares Owned By Institutions | 28.55 % | ||||
| Number Of Shares Shorted | 8.99 M | ||||
| Price To Earning | (0.62) X | ||||
| Price To Book | 1.22 X | ||||
| EBITDA | (31.35 M) | ||||
| Net Income | (30.09 M) | ||||
| Cash And Equivalents | 125.54 M | ||||
| Cash Per Share | 0.99 X | ||||
| Total Debt | 5.24 M | ||||
| Current Ratio | 35.19 X | ||||
| Book Value Per Share | 0.59 X | ||||
| Cash Flow From Operations | (20.94 M) | ||||
| Short Ratio | 13.82 X | ||||
| Earnings Per Share | (0.21) X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 12 | ||||
| Beta | 1.2 | ||||
| Market Capitalization | 86.22 M | ||||
| Total Asset | 96.25 M | ||||
| Retained Earnings | (186.29 M) | ||||
| Working Capital | 112.63 M | ||||
| Current Asset | 4.29 M | ||||
| Current Liabilities | 2.5 M | ||||
| Net Asset | 96.25 M |
About Atossa Genetics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Atossa Genetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atossa Genetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atossa Genetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington. Atossa Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.